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Material and Methods: We identified twenty-five 
glioblastoma patients treated with helical IMRT 
(Tomotherapy) with concurrent and adjuvant temozolamide 
between October 2011 and December 2013 from our 
radiotherapy electronic database and conducted a 
retrospective analysis. Hippocampi were contoured in CT and 
MRI co-registered image data sets used for clinical 
radiotherapy planning and hippocampus planning risk volumes 
(PRV) were created by adding five-millimetre isotropic 
margin which were checked by a neuro radiologist. Clinical 
treatment dosimetry plans were overlaid to obtain dose 
statistics. Four selected patients were planned for 
hippocampus avoidance radiotherapy without compromising 
tumour PTV coverage using currently established 
hippocampus dose volume histogram (DVH) constraints.  
 
Results: Mean hippocampus PRV maximum, minimum and 
mean radiation doses were 54.7, 24.15 and 38.62 Gy 
respectively. Hippocampus PRV V7.3, V14.9 and V20 were 
99.95%, 98.41% and 95.72% and hippocampus V3 was 100%. In 
seventeen patients ipsilateral hippocampus was within PTVs 
and in seven patients both hippocampi were outside PTVs 
with only minimal overlapping volumes but DVH based dose 
constraints were not achieved.  
 
 
With hippocampus avoidance planning (HA), in four patients 
hippocampus PRV minimum doses and in 3 patients mean 
hippocampus PRV doses were reduced and significant 
reductions in DVH based dose constraints were achieved in 3 
patients when compared to clinical treatment plans (table).  
 
Conclusion: Our analysis showed hippocampus PRVs received 
significant radiation doses and currently established 
hippocampus DVH based dose constraints were not achieved 
during cranial radiotherapy for glioblastoma using helical 
IMRT without hippocampus avoidance planning. Our planning 
study demonstrated significant dose reductions were possible 
with hippocampus avoidance radiotherapy planning in 
selected patients. More clinically correlated DVH objectives 
for hippocampus are required for better optimisation for 
hippocampus avoidance cranial radiotherapy in glioblastoma 
for this to be considered for all patients.  
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Purpose or Objective: To provide a comparison of 6 
different treatment planning strategies, adopted for breast 
conserving-adjuvant RT, on the dose to the PTV and OARs. 
 
Material and Methods: 22 patients CT data sets were 
retrospectively used for planning comparison. Patients were 
split in two groups of 6 left- and 5 right-sided cases (G1 and 
G2) according to the different dose prescription (50 Gy in 25 
fractions and 42.4 Gy in 16 fractions for G1 and G2, 
respectively). The 6 techniques involved were: Field in Field 
(FiF), 2 Fields static-IMRT (sIMRT-2ff), 4 Fields static-IMRT 
(sIMRT-4FF), VMAT, Helical Tomotherapy (HT) and Tomo 
Direct (TD). Dose limits applied to PTV and OARs were taken 
from the RTOG protocol n.1005. Treatments plans were 
optimized to reduce dose to Ipsilateral Lung (IL), 
Contralateral Breast (CB) and, for left-sided cases, Heart (H) 
while maintaining an acceptable PTV coverage and 
homogeneity. The Wilcoxon matched-paired signed-rank test 
was used to compare the results. The threshold for statistical 
significance was p≤0.05.  
 
Results: The highest mean value V95%=98.8%/99.2% (G1/G2) 
was observed for TD and it was statistically significant with 
respect to all others techniques except to VMAT. Similar 
results were obtained for D98%. The lowest mean 
V105%=0.2%/0.1% (G1/G2) was found for HT resulting 
statistically significant if compared to all other techniques 
except FIF/VMAT in G1 /G2, respectively. Mean D2% was also 
found lowest for HT (52.1Gy/43.1Gy in G1/G2) resulting 
statistically significant with respect to all other techniques 
except versus TD in G2. For IL mean V5(Gy), V10(Gy) and 
dose mean were lowest for TD in both groups (20.1%/19.1%, 
14.2%/13% and 5.8%/4.9% in G1/G2, respectively) being 
statistically significant versus all other techniques in G1. The 
lowest values of mean V20(Gy)=7.0%/7.9% were observed for 
HT in both groups. CB dose maximum was found as lowest in 
G1 for TD (290.9cGy) and for FiF in G2 (252,6cGy) both 
resulting statistically significant versus all other techniques 
except for FiF in G1 and TD in G2 confirming a substantial 
equivalence for the two techniques. Minor absolute dose 
differences were observed for H.  
 
Conclusion: 6 different techniques were employed to design 
an optimal plan for conserving breast-adjuvant RT fulfilling 
the dose limit criteria provided by RTOG 1005 protocol. TD 
provided superior target coverage maintaining a level of 
homogeneity similar to HT which achieved the highest value. 
IL dose was minimized with TD while dose to CB was lowest 
using both FiF and TD techniques.  
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Purpose or Objective: Preoperative Radiotherapy (RT) may 
theoretically improve resectability in locally advanced 
pancreatic cancer. However, effective doses of RT are 
limited by the tolerance of surrounding tissues. Stereotactic 
radiotherapy (SRT) with intensity-modulated technique 
(IMRT) based on the use of a Simultaneous Integrated Boost 
may theoretically allow to deliver a low dose to the 
duodenum (site of more common toxicity) and a high dose to 
the vessel invasion (more common reason of unresectability). 
Aim of this study was to perform a planning feasibility 
analysis of a modulated dose prescription within a pancreatic 
tumor treated by SRT. 
 
Material and Methods: 15 patients with a histological 
confirmation of pancreatic head adenocarcinoma with 
vascular involvement were included. The following 
definitions for targets were used: duodenal PTV (PTVd) was 
defined as the GTV overlapping the duodenal planning at risk 
volume (PRV) (from the pylorus to the duodenojejunal 
junction adding 5 mm in craniocaudal direction (CC), 3 mm in 
the other directions); vascular CTV (CTVv) was defined as the 
surface of contact or infiltration between tumor and vessel 
plus 5 mm margin around the vessel (including the whole 
